(126 days)
The SomnoMed MAS RxA is intended to reduce night time snoring and mild to moderate obstructive sleep apnea (OSA) in adults.
The Somnomed MAS RxA is an intraoral device used for treating Snoring and Sleep Apnea. It consists of two custom fitted trays which fit over the upper and lower teeth and which are positioned in relation to each other by an adjustable mechanism consisting of adjustable lugs. The device functions as a mandibular advancement device and enlarges the patient's pharyngeal space, improving their ability to exchange air during sleep. The device is custom made for each patient and has the adjustment mechanism enabling the amount of mandibular advancement to be set by the dentist or physician at the time of fitting the device.
The provided text is a 510(k) summary for the SomnoMed MAS RxA, a mandibular advancement device. It outlines the device's description, indications for use, and a summary of equivalence to a predicate device (MDSA K042161). However, it does not contain any information regarding specific acceptance criteria, performance data from a study, sample sizes, expert qualifications, or ground truth establishment.
The document is a regulatory submission for premarket notification, aiming to demonstrate substantial equivalence to a legally marketed predicate device rather than providing a detailed performance study with acceptance criteria.
Therefore, I cannot fulfill the request to provide a table of acceptance criteria and reported device performance or details about a study proving the device meets acceptance criteria, as this information is not present in the given text.
The text focuses on:
- Description of the Device: It's an intraoral device with two custom-fitted trays and adjustable lugs to improve air exchange during sleep.
- Indications For Use: To reduce night-time snoring and mild to moderate obstructive sleep apnea (OSA) in adults.
- Summary of Equivalence: It states that the Somnomed MAS RxA is substantially equivalent to the Bird MDSA device. The primary difference noted is in the adjustable mechanisms (locking clasp for MDSA vs. interlocking lugs and wings for Somnomed RxA). It also mentions that the materials used (dental acrylic, adjustment screws, ball clasps) have prior 510(k) approval.
- Risk Assessment: Concluded no new safety concerns.
In summary, the provided document is a 510(k) summary for regulatory clearance based on substantial equivalence, not a detailed performance study report.
{0}------------------------------------------------
SomnoMed
Limited A.C.N. 003 255 221
Level 3, 20 Clarke Street Crows Nest, NSW 2065 Australia
+61 2 9439 9890 Tel : +61 2 9439 9892 Fax :
JUL 1 2 2005
510(k) Summary
| Contact Person: | Elaine Duncan |
|---|---|
| Paladin Medical Inc.PO Box 560Stillwater MN 55082 | |
| Tel: (715) 549 6035Fax: (715) 549 5380 | |
| Brand Name: | SOMNOMED MAS RXA |
| Common Name: | Mandibular advancement device |
| Classification Name: | Device, anti-snoring (21CFR872.5570]) |
| Product Code: | LRK |
| Predicate Device: | MDSA K042161 |
| Date Prepared: | 3 March 2005 |
Description Of The Device: The Somnomed MAS RxA is an intraoral device used for treating Snoring and Sleep Apnea. It consists of two custom fitted trays which fit over the treading Ononing and Groop Aprilation of adjustable lugs. The device functions as a upper und lower toon and only-gests the patient's pharyngeal space, improving their ability to exchange air during sleep. The device is custom made for each patient and thas the adjustment mechanism enabling the amount of mandibular advancement to be set by the dentist or physician at the time of fitting the device.
Indications For Use: The SomnoMed MAS RxA is intended to reduce night time snoring and mild to moderate obstructive sleep apnea (OSA) in adults.
Summary of Equivalence: The Somnomed MAS RxA is considered to be substantially equivalent to the Bird MDSA device. Both the Somnomed MAS RxA and the MDSA are equivalion to the Bira hade titratable mandibular repositioning devices for the dental treatment of patients suffering snoring and mild to moderate obstructive sleep apnea.
The technical designs and manufacture of the two devices are almost identical, being r he techniour dooghe and mananavars which fit onto the upper and lower teeth and which are positioned in relation to each other by an adjustable mechanism. The only design are poollionou in relation to the adjustable mechanisms in the two devices. The MDSA difference to in the natibular advancement by means of a locking clasp placed at the front centre of the two acrylic trays, whereas the Somnomed RxA uses interlocking lugs and wings placed on the sides of the trays. The dental acrylic, adjustment screws and ball clasps used to manufacture the Somnomed MAS RxA have all been granted prior 510(k) approval for use in manufacture of dental appliances
A risk assessment concluded that there were no new safety concerns raised by the design of the Somnomed MAS RxA.
{1}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the Department of Health and Human Services (HHS). The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles an abstract human figure or a caduceus, which is a symbol often associated with medicine and healthcare.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 2 2005
:
ﻟﻠﺘﺎﺭﻳﺨﻲ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘ
Somnomed Limited C/O Ms. Elaine Duncan Paladin Medical Incorporated P.O. Box 560 Stillwater, Minnesota 55082
Re: K050592
Trade/Device Name: MAS RxA Regulation Number: 21 CFR 872.5570 Regulation Name: Intraoral Devices for Snoring and Intraoral Devices for Snoring and Obstructive Sleep Apnea Regulatory Class: II Product Code: LRK Dated: June 9, 2005 Received: June 15, 2005
Dear Ms. Duncan:
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your ever letermined the device is substantially equivalent (for the relerenced above and have attermelosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device mendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket the rederal 1 00a, Drag, and , You may, therefore, market the device, subject to the general approvisions of the Act. The general controls provisions of the Act include controls providents of annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III If your device is clusified (boo as of lotter and controls. Existing major regulations affecting (1 Mr), it may be such of Federal Regulations, Title 21, Parts 800 to 898. In your device ear or roundsh further announcements concerning your device in the Federal Register.
{2}------------------------------------------------
Page 2 -- Ms. Duncan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements modifine and regulations and regulations administered by other Federal agencies. of the Act of ally I oderal but requirements, including, but not limited to: registration r od into compry - 1 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice and if the (21 ce read in the quality systems (QS) regulation (21 CFR Part 820); and if requirements as betronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) Print reter wrification. The FDA finding of substantial equivalence of your device to a premaired predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), rf you desite spiece of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Inay obtain of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Anthony O'Connell for
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications For Use
510(k) Number (if known): K050592
Device Name: MAS RxA
$\xi$ $\eta$ $\zeta$
Indications For Use:
The SomnoMed MAS RxA is intended to reduce night time snoring and mild to moderate obstructive sleep apnea (OSA) in adults.
______________________________________________________________________________________________________________________________________________________________________________ Prescription Use
Over-The-Counter Use_ AND/OR
(Part 21 CFR 801 Subpart D)
(21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
for MSR
(Division Sign-Off) Division of Anesthesiology, Ge Infection Control, Dental
510(k) Number. K050592
§ 872.5570 Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea.
(a)
Identification. Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.(b)
Classification. Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”